End Cash: The amount of cash held by the company for the given period.
Anika Therapeutics Inc. (ANIK) had End Cash of $44.96M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$30.59M |
|
$-0.31M |
|
$11.76M |
|
$18.84M |
|
$31.31M |
|
$-0.71M |
|
$0.39M |
|
$-0.32M |
|
$-0.32M |
|
$-0.31M |
|
$-0.31M |
|
$-0.31M |
|
$-0.31M |
|
$-0.71M |
|
$0.73M |
|
13.39M |
|
13.39M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$103.05M |
|
$40.74M |
|
$86.56M |
|
$189.60M |
|
$26.73M |
|
-- |
|
$25.30M |
|
$52.02M |
|
$137.58M |
|
$128.15M |
|
$137.58M |
|
13.39M |
|
| Cash Flow Statement Financials | |
$2.85M |
|
$-4.28M |
|
$-11.07M |
|
$57.48M |
|
|
End Cash |
$44.96M |
$-12.52M |
|
$12.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
61.57% |
|
-2.33% |
|
-2.33% |
|
-- |
|
-1.05% |
|
-1.02% |
|
$-1.69M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.39 |
|
1.26 |
|
71.35 |
|
-0.23% |
|
-0.24% |
|
-0.16% |
|
-0.23% |
|
$10.27 |
|
$-0.13 |
|
$0.21 |
|